MD523F1 - Derivati noi ai triazolpirimidinei, antagonisti ai receptorilor angiotensinei II, procedee de preparare a lor, compozitii farmaceutice ce le contin - Google Patents

Derivati noi ai triazolpirimidinei, antagonisti ai receptorilor angiotensinei II, procedee de preparare a lor, compozitii farmaceutice ce le contin

Info

Publication number
MD523F1
MD523F1 MD95-0084A MD950084A MD523F1 MD 523 F1 MD523 F1 MD 523F1 MD 950084 A MD950084 A MD 950084A MD 523 F1 MD523 F1 MD 523F1
Authority
MD
Moldova
Prior art keywords
triazolpyrymidine
angiotenzine
antagonists
derivatives
preparation
Prior art date
Application number
MD95-0084A
Other languages
English (en)
Other versions
MD523G2 (ro
Inventor
Nicole Bru-Magniez
Eric Nicolai
Jean-Marie Teulon
Original Assignee
Union Pharma Scient Appl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Pharma Scient Appl filed Critical Union Pharma Scient Appl
Publication of MD523F1 publication Critical patent/MD523F1/ro
Publication of MD523G2 publication Critical patent/MD523G2/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MD95-0084A 1991-07-05 1994-12-30 Derivaţi noi ai triazolpirimidinei, antagonişti ai receptorilor angiotensinei II, procedee de preparare a lor, compoziţii farmaceutice ce le conţin MD523G2 (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9108486A FR2678618B1 (fr) 1991-07-05 1991-07-05 Nouveaux derives de triazolo pyrimidine antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.

Publications (2)

Publication Number Publication Date
MD523F1 true MD523F1 (ro) 1996-04-30
MD523G2 MD523G2 (ro) 1997-01-31

Family

ID=9414783

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0084A MD523G2 (ro) 1991-07-05 1994-12-30 Derivaţi noi ai triazolpirimidinei, antagonişti ai receptorilor angiotensinei II, procedee de preparare a lor, compoziţii farmaceutice ce le conţin

Country Status (23)

Country Link
US (1) US5217973A (ro)
EP (1) EP0521768B1 (ro)
JP (1) JP3140566B2 (ro)
KR (1) KR100243628B1 (ro)
AT (1) ATE101153T1 (ro)
AU (1) AU655288B2 (ro)
CA (1) CA2072233C (ro)
CZ (1) CZ284757B6 (ro)
DE (1) DE69200045T2 (ro)
DK (1) DK0521768T3 (ro)
EE (1) EE03003B1 (ro)
ES (1) ES2063570T3 (ro)
FR (1) FR2678618B1 (ro)
HU (2) HU220225B (ro)
IE (1) IE65635B1 (ro)
IL (1) IL102367A (ro)
LV (1) LV10717B (ro)
MD (1) MD523G2 (ro)
NZ (1) NZ243443A (ro)
RU (1) RU2103270C1 (ro)
SK (1) SK279902B6 (ro)
TW (1) TW221445B (ro)
ZA (1) ZA924954B (ro)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358950A (en) * 1991-07-05 1994-10-25 Laboratoires Upsa Triazolopyrimidine derivatives which are angiotensin II receptor antagonists
FR2687677B1 (fr) * 1992-02-24 1996-10-11 Union Pharma Scient Appl Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant.
US5387747A (en) * 1992-02-24 1995-02-07 Laboratoires Upsa Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present
US5389632A (en) * 1992-02-24 1995-02-14 Laboratoires Upsa Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists
IT1263804B (it) * 1993-01-22 1996-09-03 Luso Farmaco Inst Derivati pirimidinonici fusi con eterocicli azotati ad attivita' a ii antagonista
US5358947A (en) * 1993-09-13 1994-10-25 American Cyanamid Company Angiotensin II receptor blocking 2,3-substituted pyrazolo[1,5-a]-1,3,5-triazin-4(3H)-ones
ATE257156T1 (de) * 1997-03-24 2004-01-15 Kyowa Hakko Kogyo Kk (1,2,4)triazolo(1,5-c)pyrimidin-derivate
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2009158309A2 (en) * 2008-06-25 2009-12-30 Ligand Pharmaceuticals Inc. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
WO2023066299A1 (en) * 2021-10-19 2023-04-27 Impact Therapeutics (Shanghai) , Inc Substituted triazoloheteroaryl compounds as usp1 inhibitors and the use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US269980A (en) * 1883-01-02 Horse power
GB859287A (en) * 1958-10-03 1961-01-18 Ici Ltd Triazolopyrimidine derivatives and their preparation
GB897870A (en) * 1959-06-15 1962-05-30 Ici Ltd s-triazolo[2, 3-c]pyrimidine derivatives
GB951652A (en) * 1960-06-28 1964-03-11 Wallace Broadbent Sulphamyl triazolopyrimidines and their preparation
US4269980A (en) * 1979-12-17 1981-05-26 American Cyanamid Company (Substituted-phenyl)-1,2,4-triazolo[4,3-c]pyrimidines and (substituted-phenyl)-1,2,4-triazolo[1,5-c]pyrimidines
US4572910A (en) * 1983-03-03 1986-02-25 Riker Laboratories, Inc. Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings
US4528288A (en) * 1983-05-02 1985-07-09 Riker Laboratories, Inc. Substituted triazolo[1,5-c]pyrimidines
US4532242A (en) * 1983-05-02 1985-07-30 Riker Laboratories, Inc. Substituted triazolo[4,3-c]pyrimidines
US4562192A (en) * 1984-02-03 1985-12-31 G. D. Searle & Co. 6-Substituted-5-phenyltetrazolo[1,5-a][1,2,4]triazole[1,5-c]pyrimidines, and pharmaceutical compositions containing them
US4728652A (en) * 1985-05-20 1988-03-01 E. R. Squibb & Sons, Inc. 2-substituted thio or oxy-4-aryl or heterocyclo-5-carboxy-1,4-dihydropyrimidines, composition containing them, and method of using them to reduce blood pressure
US5010195A (en) * 1988-05-25 1991-04-23 The Dow Chemical Company Herbicidal alkoxy-1,2,4-triazolo(1,5-c)primidine-2-sulfonamides
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
EP0435827A3 (en) * 1989-12-28 1991-11-13 Ciba-Geigy Ag Diaza compounds
WO1991015209A1 (en) * 1990-03-30 1991-10-17 Merck & Co., Inc. Substituted pyrimidines, pyrimidinones and pyridopyrimidines
US5177206A (en) * 1991-10-08 1993-01-05 Dowelanco Process for the preparation of substituted N-(aryl)-1,2,4-triazolopyrimidine-2-sulfonamides

Also Published As

Publication number Publication date
DE69200045T2 (de) 1994-05-19
FR2678618B1 (fr) 1993-11-05
EP0521768A1 (fr) 1993-01-07
RU2103270C1 (ru) 1998-01-27
DK0521768T3 (da) 1994-08-15
IE922015A1 (en) 1993-01-13
TW221445B (ro) 1994-03-01
MD523G2 (ro) 1997-01-31
SK207892A3 (en) 1995-08-09
KR930002349A (ko) 1993-02-23
ATE101153T1 (de) 1994-02-15
JPH06122685A (ja) 1994-05-06
HUT63422A (en) 1993-08-30
LV10717A (lv) 1995-06-20
DE69200045D1 (de) 1994-03-17
HU211473A9 (en) 1995-11-28
CA2072233C (en) 2003-11-18
EE03003B1 (et) 1997-06-16
IL102367A (en) 1997-06-10
CA2072233A1 (en) 1993-01-06
JP3140566B2 (ja) 2001-03-05
CZ207892A3 (en) 1993-01-13
CZ284757B6 (cs) 1999-02-17
IE65635B1 (en) 1995-11-01
HU9202227D0 (en) 1992-10-28
HU220225B (hu) 2001-11-28
SK279902B6 (sk) 1999-05-07
EP0521768B1 (fr) 1994-02-02
ES2063570T3 (es) 1995-01-01
LV10717B (en) 1995-12-20
US5217973A (en) 1993-06-08
AU1939692A (en) 1993-01-07
KR100243628B1 (ko) 2000-03-02
IL102367A0 (en) 1993-01-14
ZA924954B (en) 1993-04-28
FR2678618A1 (fr) 1993-01-08
NZ243443A (en) 1995-01-27
AU655288B2 (en) 1994-12-15

Similar Documents

Publication Publication Date Title
MD523F1 (ro) Derivati noi ai triazolpirimidinei, antagonisti ai receptorilor angiotensinei II, procedee de preparare a lor, compozitii farmaceutice ce le contin
IL101203A0 (en) Cyclic urea derivatives,their preparation and pharmaceutical compositions containing them
ES8706132A1 (es) Un procedimiento para la preparacion de analogos de benzodiazepina
NZ226354A (en) Azaspirane derivatives and pharmaceutical compositions
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
IL112622A0 (en) Camptothecin derivatives, their preparation and pharmaceutical compositions containing them
JO1502B1 (en) New pharmacy vehicles
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
ES470155A1 (es) Un procedimiento para la obtencion de derivados de espiroa- mina
MD502F1 (ro) Derivati noi ai adenozinei, procedee de preparare a lor, compozitii farmaceutice ce le contin
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
IL76176A (en) Pharmaceutical compositions containing ethylenediamine monoamide derivatives,certain such novel compounds and their preparation
IL96636A0 (en) Piperidine derivatives and pharmaceutical compositions containing them
MD522F1 (ro) Noi derivati de piperidinil tioindol, procedeu de preparare a lor, compozitii farmaceutice care le contin, utilizare a lor ca analgezice
IL81410A (en) Pharmaceutical compositions containing substituted n-arylmethylamine derivatives,certain such novel compounds and their preparation
MXPA04006113A (es) Derivados de triazoloquinolina utiles como ligandos receptores de adenosina.
ES2027550A6 (es) Procedimiento para preparar derivados de glicerol.
MD553F1 (ro) Derivati noi ai pirazolopirimidinelor, antagonisti ai receptorilor angiotensinei II, procedee de preparare a lor, compozitii farmaceutice care le contin
GR1000156B (el) ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΝΕΩΝ ΠΑΡΑΓΩΓΩΝ ΤΡΙΚΥΚΛΙΚΩΝ ΑΜΙΝΩΝ ΤΗΣ ΤΕΤΡΑΥΔΡΟ-5,6,7,8ΝΑΦΘΟ[2,3b] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ & ΤΗΣ ΤΕΤΡΑΥΔΡΟ-6,7,8,9 5Η-ΒΕΝΖΟΚΥΚΛΟΕΠΤΑ[2,3Β] ΔΙΥΔΡΟ-2,3 ΦΟΥΡΑΝΗΣ.
DE3269309D1 (en) Pyrrolo(2,3-d)carbazole derivatives, preparation thereof and their therapeutical use
ES2001389A6 (es) Procedimiento para preparar derivados de o-toluidina
MD457F1 (ro) Derivati noi de naftiridina, procedeu de preparare a lor, compozitii farmaceutice care le contin, utilizarea lor ca medicamente de antireproducere
MX9706927A (es) Antagonistas biciclicos de taquicininas, preparacion de los mismos y su uso en composiciones farmaceuticas.
IL111791A0 (en) Glutaramide derivatives
EP0355689A3 (en) Pyrano [f] quinoline derivatives and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20141230

MK4A Patent for invention expired